Research Paper Volume 15, Issue 20 pp 11201—11216

Figure 5. The prognostic signature’s risk score and its correlation with survival outcomes within the UVM cohort. (A) Survival analysis of the different risk subgroups; (B) ROC curves illustrating the predictive accuracy of 1-, 3-, and 5-year survival rates based on varying risk scores; (C) Disparate expression of model genes in the different risk subgroups. (D) Distribution of the risk score in the different risk subgroups. (E) The survival status in the different risk subgroups; (F) Nomogram model for individual patient survival probabilities at 1-, 3-, and 5-year intervals for those diagnosed with UVM; (G) Calibration curves depicting the nomogram’s accuracy in relation to observed OS at 1-, 3-, and 5-year milestones.